1. Ethyl-eicosapentaenoic acid (E-EPA) supplementation in early psychosis. A double-blind add on standard therapy in 80 drug naive or early treated first episode psychosis patients;Berger;Schizophrenia Research,2004
2. Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomised placebo-controlled trial;Berger;Journal of Clinical Psychiatry,2007
3. Ethyl-Eicosapentaenoic acid (E-EPA) supplementation in early psychosis. A double-blind, randomised, placebo controlled trial (RCT) comparing 2g E-EPA versus placebo add on therapy in 80 drug naive or early treated first episode psychosis;Berger;Schizophrenia Bulletin,2005
4. McConchie MA Berger GE Proffitt TM Yuen HP Wood S smith D Horrobin D McGorry PD Effect of diagnostic heterogeneity on response to ethyl-eicosapentaenoic acid (EPA) in first episode psychosis (FEP) Proceedings of the 12th Biennial Winter Workshop on Schizophrenia; 2004 Feb 7-13, Davos, Switzerland Davos 2004
5. Ethyl-Eicosapentaenoic acid (E-EPA) supplementation in first-episode psychosis: effects on cognition mediated by lipid metabolic status;Proffitt;Schizophrenia Research,2004